Kids Walk For Pediatric Cancer Research
More than 2,500 people participated in the annual walkathon through Central Park; Every dollar raised goes to pediatric cancer research at Memorial Sloan Kettering Cancer Center
NEW YORK, May 8, 2017 /PRNewswire/ -- More than 2,500 people walked in Central Park on Saturday for the annual Kids Walk for Kids with Cancer event. This year, Kids Walk has already raised $1.2 million for pediatric cancer research at Memorial Sloan Kettering Cancer Center (MSK), with fundraising continuing through June 30.
Individuals of all ages, families and groups came together to walk the one-and-a-half mile route, starting and finishing at the event's festival near the Naumburg Bandshell. Students participated with their classmates and teachers, representing more than 30 schools.
The upbeat, family-friendly event included face painting, live music, sign making and a pre-walk stretch session. The speaking program featured cancer survivors, caregivers and doctors who shared why the event is so meaningful and inspiring to them. Participants honored and celebrated the courage and strength of Kids Walk Warriors: kids who have faced pediatric cancer, those currently battling and others lost too soon.
Kids Walk has raised more than $5 million since it was established in 2001. Every dollar goes directly to pediatric cancer research, which is notoriously underfunded. The money raised has already contributed to the discovery of new and better treatments for childhood cancers.
MSK is at the forefront of developing and improving treatment options for children, teens, and young adults with cancer. With more than 800 new patients each year, MSK's pediatric cancer program is the largest of its kind in the United States.
To donate, learn more or find out how to participate, go to www.kidswalkmsk.org.
About Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering (MSK)—the world's oldest and largest private cancer center—has devoted more than 130 years to exceptional patient care, innovative research, and outstanding educational programs. Today, it is one of 69 National Cancer Institute-designated Comprehensive Cancer Centers, with state-of-the-art science flourishing side-by-side with clinical studies and treatment. The close collaboration between MSK's physicians and scientists is one of its unique strengths, enabling it to provide patients with the best care available as researchers work to discover more effective strategies to prevent, control and ultimately cure cancer. MSK's education programs train future physicians and scientists, and the knowledge and experience they gain has an impact on cancer treatment and biomedical research around the world.
SOURCE Memorial Sloan Kettering Cancer Center
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article